# Opioid-Free Anesthesia for Mandibular Surgery in a Patient With Confirmed Opioid Hypersensitivity: A Case Report

**Authors:** Adam M Roumani, Souad Chahboune, Toufik Iaiche-Achour

PMC · DOI: 10.7759/cureus.102932 · Cureus · 2026-02-03

## TL;DR

A patient with a confirmed opioid allergy successfully underwent jaw surgery using a non-opioid anesthesia approach, avoiding allergic reactions and managing pain effectively.

## Contribution

Demonstrates a successful, fully systemic opioid-free anesthesia strategy for maxillofacial surgery in patients with opioid hypersensitivity.

## Key findings

- A multimodal non-opioid anesthesia approach was safely used for mandibular surgery in an opioid-allergic patient.
- Intraoperative stability and postoperative pain control were achieved without opioids or allergic complications.
- Patient satisfaction was high with non-opioid analgesics managing postoperative pain effectively.

## Abstract

Opioid-induced anaphylaxis is a rare but potentially life-threatening condition that represents a major challenge for perioperative pain management. We report the case of a 38-year-old woman with confirmed hypersensitivity to fentanyl and sufentanil, who underwent mandibular cyst resection under exclusive systemic opioid-free anesthesia. Following a previous aborted surgery due to an anaphylactic reaction during induction, allergy testing confirmed opioid hypersensitivity, while other intravenous anesthetics tested negative. Anesthesia was performed using a multimodal systemic approach combining dexmedetomidine, ketamine, lidocaine, magnesium sulfate, dexamethasone, and paracetamol, without regional anesthesia. Intraoperative hemodynamic parameters remained stable, and no allergic or anesthetic complications occurred. Postoperative pain was acceptable and managed with non-opioid analgesics, and patient satisfaction was high. This case highlights the feasibility of a fully systemic opioid-free anesthetic strategy in maxillofacial surgery for patients with confirmed opioid allergy.

## Linked entities

- **Chemicals:** fentanyl (PubChem CID 3345), sufentanil (PubChem CID 41693), dexmedetomidine (PubChem CID 5311068), ketamine (PubChem CID 3821), lidocaine (PubChem CID 3676), magnesium sulfate (PubChem CID 24083), dexamethasone (PubChem CID 5743), paracetamol (PubChem CID 1983)

## Full-text entities

- **Genes:** IGHE (immunoglobulin heavy constant epsilon) [NCBI Gene 3497] {aka IgE}
- **Diseases:** mandibular (MESH:D008338), Opioid Hypersensitivity (MESH:D004342), PONV (MESH:D020250), Neuromuscular blockade (MESH:D020879), cyst (MESH:D003560), clinical (MESH:D000075902), hyperalgesic (MESH:D006930), Pain (MESH:D010146), anxiety (MESH:D001007), Postoperative pain (MESH:D010149), tachycardia (MESH:D013610), anaphylactic (MESH:D000707), bradycardia (MESH:D001919), analgesia (MESH:D000699), hypotension (MESH:D007022), opioid (MESH:D009293)
- **Chemicals:** rocuronium (MESH:D000077123), OFA (-), sufentanil (MESH:D017409), lidocaine (MESH:D008012), dexamethasone (MESH:D003907), dexmedetomidine (MESH:D020927), magnesium sulfate (MESH:D008278), sugammadex (MESH:D000077122), cefazolin (MESH:D002437), sevoflurane (MESH:D000077149), Paracetamol (MESH:D000082), oxygen (MESH:D010100), metronidazole (MESH:D008795), epinephrine (MESH:D004837), latex (MESH:D007840), fentanyl (MESH:D005283), propofol (MESH:D015742), nefopam (MESH:D009340)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12966946/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12966946/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12966946/full.md

---
Source: https://tomesphere.com/paper/PMC12966946